Shares & Derivatives
Get Smart: Vaccines Ignite Hope for Swift Recovery
By The Smart Investor  •  November 28, 2020
By now, you should have heard about Pfizer’s (NYSE: PFE) potential vaccine. It’s good news for humanity. Earlier this week, there was even more good news when Moderna (NASDAQ: MRNA) reported results from its own experimental vaccine, which had a 94.5% effective rate in preventing COVID-19 based on initial results. If a vaccine can be proven to be safe and adopted widely, we could eventually see the end of the COVID-19 pandemic that has engulfed the world this year. While there was good news at one end, the stock market decided it was bad news for “work from home” stocks. Companies such as Zoom Video Communications (NASDAQ: ZM) saw its stock price fall from around US$500 to US$400 per share within a week. Likewise, Top Glove (SGX: BVA), which benefited from increased glove demand due to the pandemic, witnessed its share price declining by almost 20% since last week. Rotating in and out...
Read the full article
By The Smart Investor
The Smart Investor is co-founded by David Kuo, Joanna Sng, and Chin Hui Leong. The company was formed in late 2019 from the ashes of the Motley Fool Singapore. The Smart Investor believes that everybody can learn how to invest, smartly. We aim to educate people on how to invest smartly by providing investing education, stock commentary and market coverage for Singapore and around the world.
LEAVE A COMMENT
LEAVE A COMMENT

Your email address will not be published.

*

Your Email Address will not be published
*

Read More Articles
More from thefinance